AMERISEPlastic Products - Industrial
Amerise Biosciences Ltd — Profit & Loss Statement
₹0.59
-4.62%
Amerise Biosciences Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Normalized EBITDA | 76000.00 | -0.15 Cr | -0.13 Cr | -0.02 Cr | — |
| Total Unusual Items | 0.00 | 0.00 | 63000.00 | 0.57 Cr | — |
| Total Unusual Items Excluding Goodwill | 0.00 | 0.00 | 63000.00 | 0.57 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 76000.00 | -0.15 Cr | -0.12 Cr | 0.55 Cr | — |
| Reconciled Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Reconciled Cost Of Revenue | 0.10 Cr | 0.07 Cr | 0.02 Cr | 8.97 Cr | — |
| EBITDA | 76000.00 | -0.15 Cr | -0.12 Cr | 0.55 Cr | — |
| EBIT | 76000.00 | -0.15 Cr | -0.12 Cr | 0.55 Cr | — |
| Net Interest Income | 0.00 | 0.00 | -1000.00 | -4000.00 | — |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Normalized Income | 76000.00 | -0.15 Cr | -0.13 Cr | -0.02 Cr | — |
| Net Income From Continuing And Discontinued Operation | 76000.00 | -0.15 Cr | -0.12 Cr | 0.55 Cr | — |
| Total Expenses | -75000.00 | 0.15 Cr | 0.13 Cr | 9.03 Cr | — |
| Diluted Average Shares | 6.61 Cr | 7.30 Cr | 6.61 Cr | 6.61 Cr | — |
| Basic Average Shares | 6.61 Cr | 7.30 Cr | 6.61 Cr | 6.61 Cr | — |
| Diluted EPS | 0.00 | -0.02 | -0.02 | 0.08 | — |
| Basic EPS | 0.00 | -0.02 | -0.02 | 0.08 | — |
| Diluted NI Availto Com Stockholders | 76000.00 | -0.15 Cr | -0.12 Cr | 0.55 Cr | — |
| Net Income Common Stockholders | 76000.00 | -0.15 Cr | -0.12 Cr | 0.55 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 76000.00 | -0.15 Cr | -0.12 Cr | 0.55 Cr | — |
| Net Income Including Noncontrolling Interests | 76000.00 | -0.15 Cr | -0.12 Cr | 0.55 Cr | — |
| Net Income Continuous Operations | 76000.00 | -0.15 Cr | -0.12 Cr | 0.55 Cr | — |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Pretax Income | 76000.00 | -0.15 Cr | -0.12 Cr | 0.55 Cr | — |
| Special Income Charges | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Non Operating Interest Income Expense | 0.00 | 0.00 | -1000.00 | -4000.00 | — |
| Interest Expense Non Operating | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Operating Income | 75000.00 | -0.15 Cr | -0.13 Cr | -0.02 Cr | — |
| Operating Expense | -0.11 Cr | 0.08 Cr | 0.11 Cr | 0.06 Cr | — |
| Other Operating Expenses | 0.08 Cr | 0.11 Cr | 0.10 Cr | 0.05 Cr | — |
| Depreciation And Amortization In Income Statement | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Depreciation Income Statement | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Gross Profit | -0.10 Cr | -0.07 Cr | -0.02 Cr | 0.04 Cr | — |
| Cost Of Revenue | 0.10 Cr | 0.07 Cr | 0.02 Cr | 8.97 Cr | — |
| Total Revenue | 0.00 | 0.00 | 0.00 | 9.01 Cr | — |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 9.01 Cr | — |
| Interest Income | — | 0.04 Cr | 0.00 | 0.00 | — |
| Total Other Finance Cost | — | 3000.00 | 1000.00 | 4000.00 | 2065.00 |
| Interest Income Non Operating | — | 0.04 Cr | 0.00 | 0.00 | — |
| Selling General And Administration | — | 44000.00 | 69000.00 | 76000.00 | 0.01 Cr |
| General And Administrative Expense | — | 44000.00 | 69000.00 | 76000.00 | 0.01 Cr |
| Other Non Operating Income Expenses | — | — | 24000.00 | 0.57 Cr | -0.17 Cr |
| Write Off | — | — | — | 0.00 | 0.06 Cr |
| Selling And Marketing Expense | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Amerise Biosciences Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.